Drug Trial Radar · NCT05813288
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
Last checked: Nov 19, 2026Latest source record: Dec 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
654
Actual
Start
Mar 27, 2023
Primary completion
Dec 8, 2025
Study completion Dec 8, 2025
Sponsor
- Lead sponsor
- Areteia TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this clinical study is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma.
Conditions
- Eosinophilic Asthma
- Asthma; Eosinophilic
- Asthma
Interventions
Dexpramipexole DihydrochlorideDrug
Oral administration of dexpramipexole tablet
PlaceboDrug
Oral administration of placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized rate of severe asthma exacerbations over 52 weeks.Time frame: Day 1 (baseline, pre-dose) through Week 52
Locations
282 sites in 26 countries. Site status is shown where the registry gives one.
Research Site 30001-287
Mobile, Alabama
Research Site 30001-487
Chandler, Arizona
Research Site 30001-462
Peoria, Arizona
Research Site 30001-322
Surprise, Arizona
Research Site 30001-458
Tucson, Arizona
Research Site 30001-010
Little Rock, Arkansas
Research Site 30001-502
Canoga Park, California
Research Site 30001-485
Inglewood, California
Research Site 30001-362
Laguna Niguel, California
Research Site 30001-497
Los Angeles, California
Research Site 30001-500
Northridge, California
Research Site 30001-489
Pasadena, California
Research Site 30001-501
San Diego, California
Research Site 30001-434
San Diego, California
Research Site 30001-484
Santa Monica, California
Research Site 30001-304
Valencia, California
Research Site 30001-305
Valencia, California
Research Site 30001-291
Jacksonville, Florida
Research Site 30001-318
Maitland, Florida
Research Site 30001-311
Miami, Florida
Research Site 30001-288
Miami, Florida
Research Site 30001-310
Miami, Florida
Research Site 30001-329
Miami, Florida
Research Site 30001-082
Miami, Florida
Research Site 30001-301
Naples, Florida
Research Site 30001-348
Ocala, Florida
Research Site 30001-331
Orlando, Florida
Research Site 30001-293
Orlando, Florida
Research Site 30001-312
Pembroke Pines, Florida
Research Site 30001-429
Plantation, Florida
Research Site 30001-319
Viera, Florida
Research Site 30001-452
Dunwoody, Georgia
Research Site 30001-483
East Point, Georgia
Research Site 30001-366
Lilburn, Georgia
Research Site 30001-328
Maywood, Illinois
Research Site 30001-535
Westchester, Illinois
Research Site 30001-347
Louisville, Kentucky
Research Site 30001-437
Alexandria, Louisiana
Research Site 30001-286
Lafayette, Louisiana
Research Site 30001-313
Marrero, Louisiana
Showing 40 of 282 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.